NEW MJ NEWS

AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2021 financial results on Wednesday, February 2, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-and-full-year-2021-earnings-conference-call-301451929.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$GRWC Secures $450,000 in Bridge Financing

Grow Condos, Inc. Secures $450,000 in Bridge Financing focusing on the build…

Agra Ventures Ltd. (AGFAF) Provides Farmako-Related Update on German Legalization of Recreational Cannabis

Agra Ventures Provides Farmako-Related Update on German Legalization of Recreational Cannabis Agra…

$AMMJ Announces Product Order Of $554,271.14 From Nevada Client

American Cannabis Company Announces Product Order Of $554,271.14 From Nevada Client American…

22nd Century Group, Inc. (XXII) Announces Exclusive Worldwide Agreement with KeyGene

22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of…